Drugs / Mix vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03357289 | Nov 2017 → Nov 2018 | kidney cancer, vaccinia | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT03357276 | Nov 2017 → Nov 2018 | colorectal cancer | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
| Phase 1/2 | NCT03357315 | Nov 2017 → Nov 2018 | sarcoma, vaccinia | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mix vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03357276 ↗ |
| Modality | Vaccine | “Mix vaccine” NCT03357276 ↗ |
| Route | Subcutaneous | “Subcutaneous injection of the deltoid muscle” NCT03357276 ↗ |